• Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Germany Greece Hungary Poland +3

  • Study of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Norway Spain

  • Study of RO7126209 safety and effects given by intravenous infusion in patients with early stage or mild to moderate Alzheimer’s disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Poland Spain

  • Study of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Investigated diseases:
    Italy The Netherlands Spain

  • Study of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy Poland Spain

  • Study of acellular pertussis vaccine and its effect on whooping cough colonization in healthy adults using controlled human infection

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated diseases:
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis

    Not recruiting

    2 1
    Investigated diseases:
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Germany Greece Italy +2

powered by